Keywords: lek, construct, 7m, euro, biopharma, site, slovenian

Lek to construct 6.7M euro biopharma site

Article | 09 October 2006

Print This

Slovenian drugmaker Lek, part of Novartis' Sandoz generics division, says that it is to develop and construct a new biopharmaceuticals ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in